VC  Altitude Life Science Ventures

     Office Locations:

701 5th Avenue, Suite 5400
Seattle, WA 98104



  • Early



  • Consumer Products & Services
  • Life Sciences & Healthcare



    The Southern Ute Indian Tribe has sponsored Altitude Life Science Ventures through its wholly owned private equity division, GF Private Equity Group, LLC. Altitude acts as the seed partner and investor in such funds, partnering with experienced management teams with differentiated value-added strategies and compelling track records in their field of expertise. Sectors of interest include: Life Sciences. Altitude's initial investment into a portfolio company is between $1 to $2.5 million with a reserve of significant capital for later rounds. The firm's strategy is to have a balanced portfolio of 15 early stage life companies selected from a portfolio Pool of 35 to 40 companies.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dave Maki Co-Founder
    Steve Johnson Co-Founder


    Recent Funding Events (trailing 12 months):







      Effector Therapeutics



      Series C


      Sienna Biopharmaceuticals



      Series B


    Portfolio companies include:

        web link

      Arete Therapeutics
        web link

      BlackThorn Therapeutics
        web link

      Cambrios Technologies
        web link

      Constellation Pharmaceuticals
        web link

      Effector Therapeutics
        web link

        web link

        web link

      Limerick Neurosciences
        web link

        web link

      Sienna Biopharmaceuticals
        web link

      Siluria Technologies
        web link


    Recent News: